Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | moxonidine | 4810 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | moxonidine | 4810 | drug-path |
Gap junction | R-HSA-190861 | map04540 | moxonidine | 4810 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | moxonidine | 4810 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | moxonidine | 4810 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | moxonidine | 4810 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | moxonidine | 4810 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | moxonidine | 4810 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | terazosin | 5401 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | terazosin | 5401 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | terazosin | 5401 | drug-path |
Long-term potentiation | R-HSA-9620244 | map04720 | terazosin | 5401 | drug-path |
Gap junction | R-HSA-190861 | map04540 | terazosin | 5401 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | terazosin | 5401 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | terazosin | 5401 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | terazosin | 5401 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | terazosin | 5401 | drug-path |
Notch signaling pathway | R-HSA-157118 | map04330 | terazosin | 5401 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | cefalonium | 21743 | drug-path |
Glioma | Q9NZM4 | map05214 | alsterpaullone | 5005498 | drug-path |